Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Stock Quote Today & Recent News Athira Pharma Inc. ATHA

Athira Pharma Inc is a biotechnology company focused on developing small molecules to restore neuronal health and stop neurodegeneration. The company is developing treatments for Alzheimer's disease and Parkinson's disease.

The Power Play by The Market Herald
{{currentVideo.videoCaption}}
< Previous Video {{moreVideoText}} Next Video >

Stock Price Chart (NDAQ:ATHA)

Fundamentals Snapshot (NDAQ:ATHA)

Current News (NDAQ:ATHA)

Athira Pharma Presents Data from ACT-AD Phase 2 Proof-of-Concept Clinical Study of Fosgonimeton in Mild-to-Moderate Alzheimer's Patients at the Alzheimer's Association International Conference 2022

GlobeNewswire 5 days ago

Athira Pharma Presents Preclinical Data at the Alzheimer's Association International Conference 2022

GlobeNewswire 6 days ago

Athira Pharma to Present Clinical and Preclinical Data at Alzheimer's Association International Conference 2022

GlobeNewswire July 25, 2022

Athira Pharma Announces Topline Results from ACT-AD Phase 2 Proof of Concept Study of Fosgonimeton in Mild-to-Moderate Alzheimer's Disease

GlobeNewswire June 22, 2022

Athira Pharma Announces Formation of Scientific Advisory Board Comprised of Renowned Leaders in Neurology Research

GlobeNewswire June 7, 2022

ATHIRA PHARMA INVESTIGATION CONTINUED by Former Louisiana Attorney General: Kahn Swick & Foti, LLC Continues to Investigate the Officers and Directors of Athira Pharma, Inc. - ATHA

Business Wire May 27, 2022

ATHIRA ALERT: Bragar Eagel & Squire, P.C. Is Investigating Athira Pharma, Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm

Business Wire May 20, 2022

Shareholders Approve the Election of All Three Athira Director Nominees at 2022 Annual Meeting

GlobeNewswire May 19, 2022

Athira Issues Statement in Response to Richard A. Kayne's Suspension of His Proxy Contest

GlobeNewswire May 16, 2022

Opinion & Analysis (NDAQ:ATHA)

No current opinion is available.

Bullboard Posts (NDAQ:ATHA)